Pathologic sequelae of vascular cognitive impairment and dementia sheds light on potential targets for intervention

Alexandria E Linton1, Erica M Weekman1, Donna M Wilcock1

  • 1University of Kentucky, College of Medicine, Sanders-Brown Center on Aging, Department of Physiology, Lexington KY 40536, USA.

Insights

Vascular contributions to cognitive impairment and dementia (VCID) often co-occurs with Alzheimer's disease. This review proposes a new hypothesis linking VCID risk factors to neuroinflammation and hypoperfusion, driving dementia progression.

Area of Science:

  • Neuroscience
  • Vascular Biology
  • Dementia Research

Background:

  • Vascular contributions to cognitive impairment and dementia (VCID) is a leading cause of dementia, frequently co-occurring with Alzheimer's disease (AD).
  • The underlying mechanisms driving VCID progression remain incompletely understood.
  • Existing knowledge highlights the need for novel hypotheses to explain VCID pathogenesis.

Purpose of the Study:

  • To propose a novel hypothesis for VCID progression.
  • To link established VCID risk factors with neuroinflammation and chronic hypoperfusion.
  • To identify potential therapeutic targets for VCID.

Main Methods:

  • Review of existing literature on VCID, AD, neuroinflammation, and chronic hypoperfusion.
  • Synthesis of knowledge to formulate a novel hypothesis.
  • Identification of key molecular mediators, including vascular growth factors and matrix metalloproteinases.

Main Results:

  • Hypothesizes that neuroinflammation and chronic hypoperfusion synergistically initiate aberrant angiogenesis.
  • Proposes that these cascades lead to blood-brain barrier breakdown via vascular growth factors and matrix metalloproteinases.
  • Highlights potential therapeutic interventions targeting these neurodegenerative pathways.

Conclusions:

  • The proposed hypothesis offers a framework for understanding VCID mechanisms.
  • Aberrant angiogenesis and blood-brain barrier disruption are key consequences of synergistic signaling cascades.
  • Future research should explore therapeutic strategies targeting these identified pathways for VCID treatment.

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
246
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
626
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
155
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
212
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
24